What Does Salarius Pharmaceuticals Do?

Total employees10
HeadquartersHouston
Founded2011

Salarius Pharmaceuticals, Inc. was a clinical-stage biopharmaceutical company dedicated to developing novel cancer treatments by targeting epigenetic mechanisms. Their lead candidate, seclidemstat, was investigated for its potential in treating various cancers, including Ewing sarcoma and other sarcomas. Founded in 2011 and headquartered in Houston, Texas, Salarius focused on advancing therapies that could address significant unmet medical needs in oncology. In December 2023, Salarius Pharmaceuticals completed a merger with VolitionRx Limited, and subsequently, the combined company operates as VolitionRx. Information presented here primarily reflects Salarius Pharmaceuticals prior to its full integration and cessation of independent operations.

Where Is Salarius Pharmaceuticals's Headquarters?

HQ Function

Primarily focused on research and development, clinical trial management, and corporate operations for its oncology drug pipeline.

Notable Features:

Likely utilized shared or leased laboratory and office spaces within a larger research park or incubator (e.g., JLABS @ TMC or similar), common for clinical-stage biotech companies, providing access to advanced research equipment and collaborative environments.

Work Culture:

As a small, clinical-stage biotech, the culture was likely agile, science-driven, and highly focused, with close collaboration among a lean team of dedicated professionals. Emphasis would have been on innovation and achieving clinical milestones.

HQ Significance:

The Houston HQ's location within the Texas Medical Center provided proximity to leading research institutions, clinicians, and a rich talent pool, crucial for a biopharmaceutical company advancing novel cancer therapies.

Values Reflected in HQ: The HQ setup likely reflected values of innovation, scientific rigor, and a commitment to addressing patient needs in oncology through a lean, collaborative, and focused operational model.

Location:

Prior to its merger, Salarius Pharmaceuticals was primarily focused on clinical development within the United States. While its research aimed for global impact and it may have engaged international Contract Research Organizations (CROs) for specific trial activities, it did not maintain a significant independent global operational footprint with international offices. Its therapeutic aspirations were global, contingent on successful drug development.

Street Address:

2450 Holcombe Blvd, Suite J-702

City:

Houston

State/Province:

Texas

Country:

USA

Where Else Does Salarius Pharmaceuticals Operate Around the World?

No additional office locations available.

Buying Intent Signals for Salarius Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Salarius Pharmaceuticals? Meet the Executive Team

As of April 2025, Salarius Pharmaceuticals' leadership includes:

David J. Arthur - President and Chief Executive Officer (Pre-Merger)
Nadeem Q. Mirza - Chief Financial Officer (Pre-Merger, from Feb 2023)
William B. McVicar, Ph.D. - Chief Scientific Officer (Pre-Merger)
Daniela Santiesteban, Ph.D. - Vice President, Research and Development (Pre-Merger)

Who's Investing in Salarius Pharmaceuticals?

Salarius Pharmaceuticals has been backed by several prominent investors over the years, including:

Public Market Investors (via NASDAQ: SLRX prior to delisting)
Early-Stage Venture Capital Firms
Angel Investors
Institutional Investors (during its public tenure)
Baylor College of Medicine (related to founding technology)

What Leadership Changes Has Salarius Pharmaceuticals Seen Recently?

Hire0
Exits4

The period from May 2023 to May 2024 was defined by Salarius Pharmaceuticals' merger with VolitionRx, which was completed in December 2023. Consequently, the Salarius executive team largely transitioned out of their roles as the company was integrated into VolitionRx. Most executive news pertained to the merger rather than typical standalone hires or exits for Salarius in its final months of independent operation.

Departures

David J. Arthur, Departed Salarius Pharmaceuticals leadership role following the merger with VolitionRx.
Nadeem Q. Mirza, Departed Salarius Pharmaceuticals leadership role following the merger with VolitionRx.
William B. McVicar, Ph.D., Departed Salarius Pharmaceuticals leadership role following the merger with VolitionRx.
Daniela Santiesteban, Ph.D., Departed Salarius Pharmaceuticals leadership role following the merger with VolitionRx.

What Technology (Tech Stack) Is Used bySalarius Pharmaceuticals?

Discover the tools Salarius Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Salarius Pharmaceuticals Email Formats and Examples

Prior to its merger with VolitionRx, Salarius Pharmaceuticals likely used common corporate email formats. Emails to @salariuspharma.com are no longer active as the domain redirects or is inactive. A previously common format for the small team was likely firstinitiallast@salariuspharma.com or potentially first.last@salariuspharma.com.

finitiallast@salariuspharma.com or first.last@salariuspharma.com

Format

darthur@salariuspharma.com (example, historical format, not active)

Example

0%

Success rate

What's the Latest News About Salarius Pharmaceuticals?

GlobeNewswire • December 19, 2023

VolitionRx Announces Closing of Merger with Salarius Pharmaceuticals

VolitionRx Limited and Salarius Pharmaceuticals announced the successful completion of their merger. The combined company operates as VolitionRx Limited, focusing on Nu.Q® blood tests. Salarius common stock ceased trading and is no longer listed on Nasdaq....more

GlobeNewswire • August 10, 2023

Salarius Pharmaceuticals Announces Merger Agreement with VolitionRx

Salarius Pharmaceuticals announced it had entered into a definitive agreement to merge with VolitionRx Limited. The merger aimed to combine Salarius's pipeline and expertise with VolitionRx's Nu.Q® technology platform....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Salarius Pharmaceuticals, are just a search away.